|Articles|January 15, 2004
Glaucoma treatment still poses many obstacles
The treatment of glaucoma and the results obtained are improving, but there are still challenges facing physicians and patients, according to Harry A. Quigley, MD, the A. Edward Maumenee professor, the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore. He presented his view of the direction that glaucoma treatment is heading here at the American Academy of Ophthalmology's glaucoma subspecialty day meeting.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants IDE approval to EyeYon Medical for its US clinical study of EndoArt
2
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
3
First patient treated in ViaLase’s IDE trial
4
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
5











































.png)


